Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
03-01

DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 2.06% to $1.98 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.63% to 18,847.28 and the Dow Jones Industrial Average rising 1.39% to 43,840.91.

Inovio Pharmaceuticals Inc. closed 86.57% short of its 52-week high of $14.75, which the company achieved on April 1st.

The stock outperformed some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.79% to $165.02, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 1.26% to $26.43.

Trading volume (540,496) remained 668,992 below its 50-day average volume of 1.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 28, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 28, 2025 17:27 ET (22:27 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10